Interestingly, ALDOA-high tumors exhibited lower expression of most immune checkpoint genes, including PDCD1 (PD-1), CTLA4, TIGIT and LAG3, suggesting that ALDOA overexpression may reduce immune checkpoint activity, potentially promoting immune evasion by decreasing immune cell engagement with the tumor. This evidence concerns the gene ALDOA and neoplasm.